For dietary guidance during this period, the recommendations in foods to avoid on GLP-1 therapy still apply, as your GI system will be readjusting to normal motility
Nutrition Management of Food Allergies Course Eva Weston, RDN, LD, NBC-HWC GLP-1 Therapy for Patients with Obesity: Identifying Solutions to Optimize Nutrition Purchase this Product Learn to address challenges associated with the use of GLP-1 medications in the treatment of obesity
SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al
Despite the strengths mentioned, there are several limitations that should be acknowledged in this systematic review
Given that sensory or gastrointestinal adverse effects, such as dysgeusia and persistent nausea, can impair nutritional intake and lead to early treatment discontinuation (particularly in vulnerable populations) future research must incorporate rigorous sensory testing, larger and more diverse cohorts, and adherence-related outcomes to clarify how incretin therapies influence taste perception and long-term eating behavior (153, 157, 161)
they are from two asymptomatic patients with HD and two brains from appropriate controls